CA1085417A - Disubstituted phenol ethers of 3-amino-2- hydroxypropane, processes for their preparation and their use as medicaments - Google Patents
Disubstituted phenol ethers of 3-amino-2- hydroxypropane, processes for their preparation and their use as medicamentsInfo
- Publication number
- CA1085417A CA1085417A CA263,964A CA263964A CA1085417A CA 1085417 A CA1085417 A CA 1085417A CA 263964 A CA263964 A CA 263964A CA 1085417 A CA1085417 A CA 1085417A
- Authority
- CA
- Canada
- Prior art keywords
- hydroxy
- phenoxy
- process according
- reaction
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims abstract description 87
- 230000008569 process Effects 0.000 title claims abstract description 76
- 150000008379 phenol ethers Chemical class 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 title claims abstract description 7
- 239000003814 drug Substances 0.000 title abstract description 26
- 150000001875 compounds Chemical class 0.000 claims abstract description 82
- 239000000460 chlorine Substances 0.000 claims abstract description 23
- 150000003839 salts Chemical class 0.000 claims abstract description 16
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 12
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims abstract description 10
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 9
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 9
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 90
- 238000006243 chemical reaction Methods 0.000 claims description 87
- -1 fluoren-9-yl radical Chemical class 0.000 claims description 61
- 239000003085 diluting agent Substances 0.000 claims description 42
- 239000000047 product Substances 0.000 claims description 42
- DYFFAVRFJWYYQO-UHFFFAOYSA-N n-methyl-n-phenylaniline Chemical compound C=1C=CC=CC=1N(C)C1=CC=CC=C1 DYFFAVRFJWYYQO-UHFFFAOYSA-N 0.000 claims description 39
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 24
- 239000000126 substance Substances 0.000 claims description 24
- 239000001294 propane Substances 0.000 claims description 21
- 239000007858 starting material Substances 0.000 claims description 21
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 18
- 125000004432 carbon atom Chemical group C* 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
- 229910021529 ammonia Inorganic materials 0.000 claims description 12
- 150000003254 radicals Chemical class 0.000 claims description 12
- 230000009471 action Effects 0.000 claims description 11
- 125000006239 protecting group Chemical group 0.000 claims description 11
- 239000000376 reactant Substances 0.000 claims description 11
- 150000001412 amines Chemical class 0.000 claims description 10
- 239000012458 free base Substances 0.000 claims description 10
- OUGMRQJTULXVDC-UHFFFAOYSA-N 9h-fluoren-9-amine Chemical compound C1=CC=C2C(N)C3=CC=CC=C3C2=C1 OUGMRQJTULXVDC-UHFFFAOYSA-N 0.000 claims description 9
- 230000007062 hydrolysis Effects 0.000 claims description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- 238000005915 ammonolysis reaction Methods 0.000 claims description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- 150000002989 phenols Chemical class 0.000 claims description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 5
- 239000011230 binding agent Substances 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- 125000003700 epoxy group Chemical group 0.000 claims description 5
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 3
- 229910000039 hydrogen halide Inorganic materials 0.000 claims description 3
- 239000012433 hydrogen halide Substances 0.000 claims description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 claims description 3
- 239000001117 sulphuric acid Substances 0.000 claims description 3
- 235000011149 sulphuric acid Nutrition 0.000 claims description 3
- 125000001118 alkylidene group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 4
- 125000005948 methanesulfonyloxy group Chemical group 0.000 claims 4
- 239000007795 chemical reaction product Substances 0.000 claims 2
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 20
- 230000002490 cerebral effect Effects 0.000 abstract description 6
- 229940124597 therapeutic agent Drugs 0.000 abstract description 4
- 238000002844 melting Methods 0.000 description 73
- 230000008018 melting Effects 0.000 description 73
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 63
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 46
- 239000013078 crystal Substances 0.000 description 44
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 42
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 39
- 239000000243 solution Substances 0.000 description 32
- 238000009835 boiling Methods 0.000 description 25
- 235000019441 ethanol Nutrition 0.000 description 23
- 229960004592 isopropanol Drugs 0.000 description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 14
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 14
- RXPRRQLKFXBCSJ-GIVPXCGWSA-N vincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@](O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-GIVPXCGWSA-N 0.000 description 14
- 241000282326 Felis catus Species 0.000 description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 13
- 208000000044 Amnesia Diseases 0.000 description 12
- 208000031091 Amnestic disease Diseases 0.000 description 12
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 12
- 230000006986 amnesia Effects 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- PXIKRTCSSLJURC-UHFFFAOYSA-N Dihydroeugenol Chemical compound CCCC1=CC=C(O)C(OC)=C1 PXIKRTCSSLJURC-UHFFFAOYSA-N 0.000 description 11
- 239000002585 base Substances 0.000 description 11
- 239000008194 pharmaceutical composition Substances 0.000 description 11
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 10
- 230000001681 protective effect Effects 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 8
- 229930195733 hydrocarbon Natural products 0.000 description 8
- 150000002430 hydrocarbons Chemical class 0.000 description 8
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 7
- 150000001298 alcohols Chemical class 0.000 description 7
- 229910052783 alkali metal Inorganic materials 0.000 description 7
- 150000001340 alkali metals Chemical class 0.000 description 7
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 7
- 229960000876 cinnarizine Drugs 0.000 description 7
- RXPRRQLKFXBCSJ-UHFFFAOYSA-N dl-Vincamin Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-UHFFFAOYSA-N 0.000 description 7
- 150000002170 ethers Chemical class 0.000 description 7
- 150000003840 hydrochlorides Chemical class 0.000 description 7
- 229910000027 potassium carbonate Inorganic materials 0.000 description 7
- 229940093956 potassium carbonate Drugs 0.000 description 7
- 238000001953 recrystallisation Methods 0.000 description 7
- 229960002726 vincamine Drugs 0.000 description 7
- 229940126062 Compound A Drugs 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000003727 cerebral blood flow Effects 0.000 description 6
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 6
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 6
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 5
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- FYJJXENSONZJRG-UHFFFAOYSA-N bencyclane Chemical compound C=1C=CC=CC=1CC1(OCCCN(C)C)CCCCCC1 FYJJXENSONZJRG-UHFFFAOYSA-N 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- PHDKURQHOBPQTI-UHFFFAOYSA-N 1-(benzhydrylamino)-3-chloropropan-2-ol Chemical compound C=1C=CC=CC=1C(NCC(CCl)O)C1=CC=CC=C1 PHDKURQHOBPQTI-UHFFFAOYSA-N 0.000 description 4
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 4
- 206010008120 Cerebral ischaemia Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 4
- 150000008041 alkali metal carbonates Chemical class 0.000 description 4
- 230000001427 coherent effect Effects 0.000 description 4
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 4
- 239000008298 dragée Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 229960003712 propranolol Drugs 0.000 description 4
- WDNBURPWRNALGP-UHFFFAOYSA-N 3,4-Dichlorophenol Chemical compound OC1=CC=C(Cl)C(Cl)=C1 WDNBURPWRNALGP-UHFFFAOYSA-N 0.000 description 3
- GYRCGAFFGHLKCM-UHFFFAOYSA-N 3-benzhydryl-5-(chloromethyl)-1,3-oxazolidine Chemical compound C1OC(CCl)CN1C(C=1C=CC=CC=1)C1=CC=CC=C1 GYRCGAFFGHLKCM-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000005770 Eugenol Substances 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 229960002217 eugenol Drugs 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003797 solvolysis reaction Methods 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- XGXCTVMEVYVOBT-UHFFFAOYSA-N 1-(benzhydrylamino)-3-(2-methoxy-4-propylphenoxy)propan-2-ol;hydrochloride Chemical compound Cl.COC1=CC(CCC)=CC=C1OCC(O)CNC(C=1C=CC=CC=1)C1=CC=CC=C1 XGXCTVMEVYVOBT-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- RADIRXJQODWKGQ-HWKANZROSA-N 2-Ethoxy-5-(1-propenyl)phenol Chemical compound CCOC1=CC=C(\C=C\C)C=C1O RADIRXJQODWKGQ-HWKANZROSA-N 0.000 description 2
- NTMMJCXPHYKNSP-UHFFFAOYSA-N 2-[(2,4-dichlorophenoxy)methyl]oxirane Chemical compound ClC1=CC(Cl)=CC=C1OCC1OC1 NTMMJCXPHYKNSP-UHFFFAOYSA-N 0.000 description 2
- GOXHFCVZSAKGPI-UHFFFAOYSA-N 2-[(2-chloro-6-methylphenoxy)methyl]oxirane Chemical compound CC1=CC=CC(Cl)=C1OCC1OC1 GOXHFCVZSAKGPI-UHFFFAOYSA-N 0.000 description 2
- JVGCHPPVSQHJBL-UHFFFAOYSA-N 2-[(3-ethyl-5-methylphenoxy)methyl]oxirane Chemical compound CCC1=CC(C)=CC(OCC2OC2)=C1 JVGCHPPVSQHJBL-UHFFFAOYSA-N 0.000 description 2
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000206672 Gelidium Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000000150 Sympathomimetic Substances 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- ZDVDCDLBOLSVGM-UHFFFAOYSA-N [chloro(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(Cl)C1=CC=CC=C1 ZDVDCDLBOLSVGM-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000001800 adrenalinergic effect Effects 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 235000012216 bentonite Nutrition 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 239000002981 blocking agent Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- OQROAIRCEOBYJA-UHFFFAOYSA-N bromodiphenylmethane Chemical compound C=1C=CC=CC=1C(Br)C1=CC=CC=C1 OQROAIRCEOBYJA-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000007859 condensation product Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002118 epoxides Chemical class 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 210000004124 hock Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 description 2
- SAPXZQMHJDUSCA-UHFFFAOYSA-N n-(oxiran-2-ylmethyl)-9h-fluoren-9-amine Chemical class C12=CC=CC=C2C2=CC=CC=C2C1NCC1CO1 SAPXZQMHJDUSCA-UHFFFAOYSA-N 0.000 description 2
- NRPLRSMUIHGFPI-UHFFFAOYSA-N n-benzhydrylpropan-1-amine Chemical compound C=1C=CC=CC=1C(NCCC)C1=CC=CC=C1 NRPLRSMUIHGFPI-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- MLUBYFYZEODFQW-UHFFFAOYSA-N 1-(3,4-dimethoxyphenoxy)-3-iodopropan-2-ol Chemical compound COC1=CC=C(OCC(O)CI)C=C1OC MLUBYFYZEODFQW-UHFFFAOYSA-N 0.000 description 1
- SLBVGHQBJWRUEH-UHFFFAOYSA-N 1-(benzhydrylamino)-3-(2,4-dichlorophenoxy)propan-2-ol;hydrochloride Chemical compound Cl.C=1C=C(Cl)C=C(Cl)C=1OCC(O)CNC(C=1C=CC=CC=1)C1=CC=CC=C1 SLBVGHQBJWRUEH-UHFFFAOYSA-N 0.000 description 1
- RKAGIVYCSGSNKK-UHFFFAOYSA-N 1-(benzhydrylamino)-3-(2,5-dichlorophenoxy)propan-2-ol;hydrochloride Chemical compound Cl.C=1C(Cl)=CC=C(Cl)C=1OCC(O)CNC(C=1C=CC=CC=1)C1=CC=CC=C1 RKAGIVYCSGSNKK-UHFFFAOYSA-N 0.000 description 1
- MPRJSPNDHSHDSO-UHFFFAOYSA-N 1-(benzhydrylamino)-3-(2,6-dichlorophenoxy)propan-2-ol;hydrochloride Chemical compound Cl.ClC=1C=CC=C(Cl)C=1OCC(O)CNC(C=1C=CC=CC=1)C1=CC=CC=C1 MPRJSPNDHSHDSO-UHFFFAOYSA-N 0.000 description 1
- IKAGWPYKWGKONC-UHFFFAOYSA-N 1-(benzhydrylamino)-3-(2-chloro-6-methylphenoxy)propan-2-ol;hydrochloride Chemical compound Cl.CC1=CC=CC(Cl)=C1OCC(O)CNC(C=1C=CC=CC=1)C1=CC=CC=C1 IKAGWPYKWGKONC-UHFFFAOYSA-N 0.000 description 1
- NEASDWUZBRTSLM-UHFFFAOYSA-N 1-(benzhydrylamino)-3-(3,4-dichlorophenoxy)propan-2-ol Chemical compound C=1C=C(Cl)C(Cl)=CC=1OCC(O)CNC(C=1C=CC=CC=1)C1=CC=CC=C1 NEASDWUZBRTSLM-UHFFFAOYSA-N 0.000 description 1
- FXFPUOSYVOITME-UHFFFAOYSA-N 1-(benzhydrylamino)-3-(3-chloro-2-methylphenoxy)propan-2-ol;hydrochloride Chemical compound Cl.CC1=C(Cl)C=CC=C1OCC(O)CNC(C=1C=CC=CC=1)C1=CC=CC=C1 FXFPUOSYVOITME-UHFFFAOYSA-N 0.000 description 1
- CBNHLSVSFVZARM-UHFFFAOYSA-N 1-(benzhydrylamino)-3-(3-ethyl-5-methylphenoxy)propan-2-ol;hydrochloride Chemical compound Cl.CCC1=CC(C)=CC(OCC(O)CNC(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 CBNHLSVSFVZARM-UHFFFAOYSA-N 0.000 description 1
- GZFSQWVTRGNOJS-UHFFFAOYSA-N 1-amino-3-(2,5-dichlorophenoxy)propan-2-ol Chemical compound NCC(O)COC1=CC(Cl)=CC=C1Cl GZFSQWVTRGNOJS-UHFFFAOYSA-N 0.000 description 1
- QAZFDMRCUMZKGE-UHFFFAOYSA-N 1-amino-3-(2,5-diethoxyphenoxy)propan-2-ol Chemical compound CCOC1=CC=C(OCC)C(OCC(O)CN)=C1 QAZFDMRCUMZKGE-UHFFFAOYSA-N 0.000 description 1
- FPMZNNDIIMFKDZ-UHFFFAOYSA-N 1-amino-3-(2,6-dimethylphenoxy)propan-2-ol Chemical compound CC1=CC=CC(C)=C1OCC(O)CN FPMZNNDIIMFKDZ-UHFFFAOYSA-N 0.000 description 1
- BGYAHADLDZGCDL-UHFFFAOYSA-N 1-amino-3-(2-chloro-4-ethoxyphenoxy)propan-2-ol Chemical compound CCOC1=CC=C(OCC(O)CN)C(Cl)=C1 BGYAHADLDZGCDL-UHFFFAOYSA-N 0.000 description 1
- GBCIXIIYYUQCBX-UHFFFAOYSA-N 1-amino-3-(2-chloro-5-ethoxyphenoxy)propan-2-ol Chemical compound CCOC1=CC=C(Cl)C(OCC(O)CN)=C1 GBCIXIIYYUQCBX-UHFFFAOYSA-N 0.000 description 1
- CNAPCZYKSNMYMJ-UHFFFAOYSA-N 1-amino-3-(2-chloro-6-methylphenoxy)propan-2-ol Chemical compound CC1=CC=CC(Cl)=C1OCC(O)CN CNAPCZYKSNMYMJ-UHFFFAOYSA-N 0.000 description 1
- DOGREOSDBRPYJE-UHFFFAOYSA-N 1-amino-3-(2-methoxy-4-propylphenoxy)propan-2-ol Chemical compound CCCC1=CC=C(OCC(O)CN)C(OC)=C1 DOGREOSDBRPYJE-UHFFFAOYSA-N 0.000 description 1
- ROAQEIHOMUAFIT-UHFFFAOYSA-N 1-amino-3-(3,4-dichlorophenoxy)propan-2-ol Chemical compound NCC(O)COC1=CC=C(Cl)C(Cl)=C1 ROAQEIHOMUAFIT-UHFFFAOYSA-N 0.000 description 1
- VLPVGNNEHDILGJ-UHFFFAOYSA-N 1-amino-3-(3-chloro-2-methylphenoxy)propan-2-ol Chemical compound CC1=C(Cl)C=CC=C1OCC(O)CN VLPVGNNEHDILGJ-UHFFFAOYSA-N 0.000 description 1
- PQEPDZDBJCOZEQ-UHFFFAOYSA-N 1-amino-3-(4-chloro-2-ethoxyphenoxy)propan-2-ol Chemical compound CCOC1=CC(Cl)=CC=C1OCC(O)CN PQEPDZDBJCOZEQ-UHFFFAOYSA-N 0.000 description 1
- QCGSNMJLBCAESQ-UHFFFAOYSA-N 1-amino-3-(4-chloro-2-methoxyphenoxy)propan-2-ol Chemical compound COC1=CC(Cl)=CC=C1OCC(O)CN QCGSNMJLBCAESQ-UHFFFAOYSA-N 0.000 description 1
- UHXXFDYPMQDIRX-UHFFFAOYSA-N 1-amino-3-(5-chloro-2-methoxyphenoxy)propan-2-ol Chemical compound COC1=CC=C(Cl)C=C1OCC(O)CN UHXXFDYPMQDIRX-UHFFFAOYSA-N 0.000 description 1
- ACSUGBDFOJEQGJ-UHFFFAOYSA-N 1-bromo-3-(2-chloro-5-ethoxyphenoxy)propan-2-ol Chemical compound CCOC1=CC=C(Cl)C(OCC(O)CBr)=C1 ACSUGBDFOJEQGJ-UHFFFAOYSA-N 0.000 description 1
- RBDXACGEAJLLBI-UHFFFAOYSA-N 1-bromo-3-(2-methoxy-4-propylphenoxy)propan-2-ol Chemical compound CCCC1=CC=C(OCC(O)CBr)C(OC)=C1 RBDXACGEAJLLBI-UHFFFAOYSA-N 0.000 description 1
- MZFSGVKCFBCMDG-UHFFFAOYSA-N 1-bromo-3-(3-chloro-4-methoxyphenoxy)propan-2-ol Chemical compound COC1=CC=C(OCC(O)CBr)C=C1Cl MZFSGVKCFBCMDG-UHFFFAOYSA-N 0.000 description 1
- HEMFWIZUCLKSSE-UHFFFAOYSA-N 1-chloro-3-(2,5-diethoxyphenoxy)propan-2-ol Chemical compound CCOC1=CC=C(OCC)C(OCC(O)CCl)=C1 HEMFWIZUCLKSSE-UHFFFAOYSA-N 0.000 description 1
- KKDKGDIZNFWULM-UHFFFAOYSA-N 1-chloro-3-(3-chloro-2-methylphenoxy)propan-2-ol Chemical compound CC1=C(Cl)C=CC=C1OCC(O)CCl KKDKGDIZNFWULM-UHFFFAOYSA-N 0.000 description 1
- SGLISTSTKWEDIM-UHFFFAOYSA-N 1-chloro-3-(4-chloro-3-ethoxyphenoxy)propan-2-ol Chemical compound CCOC1=CC(OCC(O)CCl)=CC=C1Cl SGLISTSTKWEDIM-UHFFFAOYSA-N 0.000 description 1
- CNDREGNITQBDLK-UHFFFAOYSA-N 1-chloro-3-(5-chloro-2-methoxyphenoxy)propan-2-ol Chemical compound COC1=CC=C(Cl)C=C1OCC(O)CCl CNDREGNITQBDLK-UHFFFAOYSA-N 0.000 description 1
- HXVHYSLYTKXUOC-UHFFFAOYSA-N 1-chloro-3-(9h-fluoren-9-ylamino)propan-2-ol Chemical compound C1=CC=C2C(NCC(CCl)O)C3=CC=CC=C3C2=C1 HXVHYSLYTKXUOC-UHFFFAOYSA-N 0.000 description 1
- PMHHCLXJMNLEIE-UHFFFAOYSA-N 1-iodopropan-2-ol Chemical compound CC(O)CI PMHHCLXJMNLEIE-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- WSNDAYQNZRJGMJ-UHFFFAOYSA-N 2,2,2-trifluoroethanone Chemical compound FC(F)(F)[C]=O WSNDAYQNZRJGMJ-UHFFFAOYSA-N 0.000 description 1
- LNSCNEJNLACZPA-UHFFFAOYSA-N 2,3-dihydroxy-2,3-bis(2-methylphenyl)butanedioic acid Chemical compound CC1=CC=CC=C1C(O)(C(O)=O)C(O)(C(O)=O)C1=CC=CC=C1C LNSCNEJNLACZPA-UHFFFAOYSA-N 0.000 description 1
- JECYNCQXXKQDJN-UHFFFAOYSA-N 2-(2-methylhexan-2-yloxymethyl)oxirane Chemical compound CCCCC(C)(C)OCC1CO1 JECYNCQXXKQDJN-UHFFFAOYSA-N 0.000 description 1
- BKYYOPSMOZNITO-UHFFFAOYSA-N 2-[(2,5-dichlorophenoxy)methyl]oxirane Chemical compound ClC1=CC=C(Cl)C(OCC2OC2)=C1 BKYYOPSMOZNITO-UHFFFAOYSA-N 0.000 description 1
- WHQHRAIGKCTLRE-UHFFFAOYSA-N 2-[(2,5-diethoxyphenoxy)methyl]oxirane Chemical compound CCOC1=CC=C(OCC)C(OCC2OC2)=C1 WHQHRAIGKCTLRE-UHFFFAOYSA-N 0.000 description 1
- GTPYUQMUVPCWKN-UHFFFAOYSA-N 2-[(2,6-dimethoxyphenoxy)methyl]oxirane Chemical compound COC1=CC=CC(OC)=C1OCC1OC1 GTPYUQMUVPCWKN-UHFFFAOYSA-N 0.000 description 1
- VHWHISLSSKROOL-UHFFFAOYSA-N 2-[(2,6-dimethylphenoxy)methyl]oxirane Chemical compound CC1=CC=CC(C)=C1OCC1OC1 VHWHISLSSKROOL-UHFFFAOYSA-N 0.000 description 1
- UHDHYICGRPOSSU-UHFFFAOYSA-N 2-[(2-chloro-4-ethoxyphenoxy)methyl]oxirane Chemical compound ClC1=CC(OCC)=CC=C1OCC1OC1 UHDHYICGRPOSSU-UHFFFAOYSA-N 0.000 description 1
- AXRAEKKCAUXVTA-UHFFFAOYSA-N 2-[(2-chloro-5-ethoxyphenoxy)methyl]oxirane Chemical compound CCOC1=CC=C(Cl)C(OCC2OC2)=C1 AXRAEKKCAUXVTA-UHFFFAOYSA-N 0.000 description 1
- UASPPRLOUSJLJY-UHFFFAOYSA-N 2-[(2-methoxy-4-propylphenoxy)methyl]oxirane Chemical compound COC1=CC(CCC)=CC=C1OCC1OC1 UASPPRLOUSJLJY-UHFFFAOYSA-N 0.000 description 1
- NXZRPCSZNMYJTR-UHFFFAOYSA-N 2-[(3,4-dimethoxyphenoxy)methyl]oxirane Chemical compound C1=C(OC)C(OC)=CC=C1OCC1OC1 NXZRPCSZNMYJTR-UHFFFAOYSA-N 0.000 description 1
- PWDZRJSPCYBMAQ-UHFFFAOYSA-N 2-[(3-chloro-4-methoxyphenoxy)methyl]oxirane Chemical compound C1=C(Cl)C(OC)=CC=C1OCC1OC1 PWDZRJSPCYBMAQ-UHFFFAOYSA-N 0.000 description 1
- NTQSOVBVOZOUET-UHFFFAOYSA-N 2-[(4-chloro-2-ethoxyphenoxy)methyl]oxirane Chemical compound CCOC1=CC(Cl)=CC=C1OCC1OC1 NTQSOVBVOZOUET-UHFFFAOYSA-N 0.000 description 1
- CFPDZLJTWSBXLP-UHFFFAOYSA-N 2-[(4-chloro-2-methoxyphenoxy)methyl]oxirane Chemical compound COC1=CC(Cl)=CC=C1OCC1OC1 CFPDZLJTWSBXLP-UHFFFAOYSA-N 0.000 description 1
- DTEKUBXHFYXKRL-UHFFFAOYSA-N 2-[(5-chloro-2-methoxyphenoxy)methyl]oxirane Chemical compound COC1=CC=C(Cl)C=C1OCC1OC1 DTEKUBXHFYXKRL-UHFFFAOYSA-N 0.000 description 1
- FYELSNVLZVIGTI-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-5-ethylpyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1CC)CC(=O)N1CC2=C(CC1)NN=N2 FYELSNVLZVIGTI-UHFFFAOYSA-N 0.000 description 1
- GOPUCFKUFOFEIC-UHFFFAOYSA-N 2-methyl-1,3-oxazolidine Chemical compound CC1NCCO1 GOPUCFKUFOFEIC-UHFFFAOYSA-N 0.000 description 1
- NEPZNZLPTYFTIV-UHFFFAOYSA-N 3-(9h-fluoren-9-ylamino)propan-1-ol Chemical compound C1=CC=C2C(NCCCO)C3=CC=CC=C3C2=C1 NEPZNZLPTYFTIV-UHFFFAOYSA-N 0.000 description 1
- ABWLGEWGKOXLRO-UHFFFAOYSA-N 3-(benzhydrylamino)propan-1-ol Chemical compound C=1C=CC=CC=1C(NCCCO)C1=CC=CC=C1 ABWLGEWGKOXLRO-UHFFFAOYSA-N 0.000 description 1
- KFDOGLIXMAWWKL-UHFFFAOYSA-N 3-benzhydryl-5-[(2-methoxy-4-propylphenoxy)methyl]-1,3-oxazolidin-2-one Chemical compound COC1=CC(CCC)=CC=C1OCC1OC(=O)N(C(C=2C=CC=CC=2)C=2C=CC=CC=2)C1 KFDOGLIXMAWWKL-UHFFFAOYSA-N 0.000 description 1
- BIWPNGWESBCPHB-UHFFFAOYSA-N 3-benzhydryl-5-[(2-methoxy-4-propylphenoxy)methyl]-1,3-oxazolidine Chemical compound COC1=CC(CCC)=CC=C1OCC1OCN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)C1 BIWPNGWESBCPHB-UHFFFAOYSA-N 0.000 description 1
- MGGVALXERJRIRO-UHFFFAOYSA-N 4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-2-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-1H-pyrazol-5-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)O MGGVALXERJRIRO-UHFFFAOYSA-N 0.000 description 1
- PXACTUVBBMDKRW-UHFFFAOYSA-N 4-bromobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Br)C=C1 PXACTUVBBMDKRW-UHFFFAOYSA-N 0.000 description 1
- GEPMAHVDJHFBJI-UHFFFAOYSA-N 7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione;pyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC=CN=C1.CN1C(=O)N(C)C(=O)C2=C1N=CN2CC(O)CN(CCO)C GEPMAHVDJHFBJI-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- AHCDKANCCBEQJJ-UHFFFAOYSA-N 9-bromo-9h-fluorene Chemical compound C1=CC=C2C(Br)C3=CC=CC=C3C2=C1 AHCDKANCCBEQJJ-UHFFFAOYSA-N 0.000 description 1
- CYSPWCARDHRYJX-UHFFFAOYSA-N 9h-fluoren-1-amine Chemical compound C12=CC=CC=C2CC2=C1C=CC=C2N CYSPWCARDHRYJX-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- HNUALPPJLMYHDK-UHFFFAOYSA-N C[CH]C Chemical compound C[CH]C HNUALPPJLMYHDK-UHFFFAOYSA-N 0.000 description 1
- DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- NTTUCPVKLKXXRZ-UHFFFAOYSA-N Cl.C(C1=CC=CC=C1)(C1=CC=CC=C1)NCC(C)O Chemical compound Cl.C(C1=CC=CC=C1)(C1=CC=CC=C1)NCC(C)O NTTUCPVKLKXXRZ-UHFFFAOYSA-N 0.000 description 1
- SMSCQLMAFZLVRU-UHFFFAOYSA-N Cl.C1(=CC=CC=C1)C(C1=CC=CC=C1)NCCC Chemical compound Cl.C1(=CC=CC=C1)C(C1=CC=CC=C1)NCCC SMSCQLMAFZLVRU-UHFFFAOYSA-N 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- 101100073738 Escherichia coli (strain K12) kgtP gene Proteins 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- BREIWTLUAQVIPK-UHFFFAOYSA-N N-methyl-1,1-diphenylpropan-1-amine Chemical compound C1(=CC=CC=C1)C(CC)(NC)C1=CC=CC=C1 BREIWTLUAQVIPK-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- GMZVRMREEHBGGF-UHFFFAOYSA-N Piracetam Chemical compound NC(=O)CN1CCCC1=O GMZVRMREEHBGGF-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000000219 Sympatholytic Substances 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 1
- MAURSHIXZFTJEX-UHFFFAOYSA-N [1-(benzhydrylamino)-3-(2-methoxy-4-propylphenoxy)propan-2-yl] acetate Chemical compound COC1=CC(CCC)=CC=C1OCC(OC(C)=O)CNC(C=1C=CC=CC=1)C1=CC=CC=C1 MAURSHIXZFTJEX-UHFFFAOYSA-N 0.000 description 1
- RSPUARPQIVSWQD-UHFFFAOYSA-N [1-(benzhydrylamino)-3-(3,4-dichlorophenoxy)propan-2-yl] acetate Chemical compound C=1C=C(Cl)C(Cl)=CC=1OCC(OC(=O)C)CNC(C=1C=CC=CC=1)C1=CC=CC=C1 RSPUARPQIVSWQD-UHFFFAOYSA-N 0.000 description 1
- YLSRBQSEZLXWKA-UHFFFAOYSA-N [3-(3,4-dichlorophenoxy)-2-hydroxypropyl] phenylmethanesulfonate Chemical compound ClC=1C=C(OCC(COS(=O)(=O)CC2=CC=CC=C2)O)C=CC=1Cl YLSRBQSEZLXWKA-UHFFFAOYSA-N 0.000 description 1
- GHVZOJONCUEWAV-UHFFFAOYSA-N [K].CCO Chemical compound [K].CCO GHVZOJONCUEWAV-UHFFFAOYSA-N 0.000 description 1
- 125000004036 acetal group Chemical group 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229940095076 benzaldehyde Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- XENVCRGQTABGKY-ZHACJKMWSA-N chlorohydrin Chemical compound CC#CC#CC#CC#C\C=C\C(Cl)CO XENVCRGQTABGKY-ZHACJKMWSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002920 convulsive effect Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- MGHPNCMVUAKAIE-UHFFFAOYSA-N diphenylmethanamine Chemical class C=1C=CC=CC=1C(N)C1=CC=CC=C1 MGHPNCMVUAKAIE-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- DCEXHSKWHSDULV-UHFFFAOYSA-N ethyl 2-(3-amino-2-hydroxypropoxy)-5-methoxybenzoate Chemical compound CCOC(=O)C1=CC(OC)=CC=C1OCC(O)CN DCEXHSKWHSDULV-UHFFFAOYSA-N 0.000 description 1
- MNUQNXJPKLFMEE-UHFFFAOYSA-N ethyl 2-(3-chloro-2-hydroxypropoxy)-4-methoxybenzoate Chemical compound CCOC(=O)C1=CC=C(OC)C=C1OCC(O)CCl MNUQNXJPKLFMEE-UHFFFAOYSA-N 0.000 description 1
- XCVPICGGNQPNIF-UHFFFAOYSA-N ethyl 3-(3-amino-2-hydroxypropoxy)-4-ethoxybenzoate Chemical compound CCOC(=O)C1=CC=C(OCC)C(OCC(O)CN)=C1 XCVPICGGNQPNIF-UHFFFAOYSA-N 0.000 description 1
- VKGJIYSZMKGHKS-UHFFFAOYSA-N ethyl 3-[3-(benzhydrylamino)-2-hydroxypropoxy]-4-methoxybenzoate;hydrochloride Chemical compound Cl.CCOC(=O)C1=CC=C(OC)C(OCC(O)CNC(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 VKGJIYSZMKGHKS-UHFFFAOYSA-N 0.000 description 1
- MHGBJOBMERORCD-UHFFFAOYSA-N ethyl 4-(3-amino-2-hydroxypropoxy)-3-ethoxybenzoate Chemical compound CCOC(=O)C1=CC=C(OCC(O)CN)C(OCC)=C1 MHGBJOBMERORCD-UHFFFAOYSA-N 0.000 description 1
- JQQGJNMPNQCDBF-UHFFFAOYSA-N ethyl 4-ethoxy-3-(oxiran-2-ylmethoxy)benzoate Chemical compound CCOC(=O)C1=CC=C(OCC)C(OCC2OC2)=C1 JQQGJNMPNQCDBF-UHFFFAOYSA-N 0.000 description 1
- DOKIXSLTUULZHG-UHFFFAOYSA-N ethyl 4-methoxy-2-(oxiran-2-ylmethoxy)benzoate Chemical compound CCOC(=O)C1=CC=C(OC)C=C1OCC1OC1 DOKIXSLTUULZHG-UHFFFAOYSA-N 0.000 description 1
- DCRWAMUURHHXIK-UHFFFAOYSA-N ethyl 4-methoxy-3-(oxiran-2-ylmethoxy)benzoate Chemical compound CCOC(=O)C1=CC=C(OC)C(OCC2OC2)=C1 DCRWAMUURHHXIK-UHFFFAOYSA-N 0.000 description 1
- NGSWMFHRDPJCLP-UHFFFAOYSA-N ethyl 5-ethoxy-2-(oxiran-2-ylmethoxy)benzoate Chemical compound CCOC(=O)C1=CC(OCC)=CC=C1OCC1OC1 NGSWMFHRDPJCLP-UHFFFAOYSA-N 0.000 description 1
- AGPXRPDOSAAPSC-UHFFFAOYSA-N ethyl 5-methoxy-2-(oxiran-2-ylmethoxy)benzoate Chemical compound CCOC(=O)C1=CC(OC)=CC=C1OCC1OC1 AGPXRPDOSAAPSC-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 229960002428 fentanyl Drugs 0.000 description 1
- IVLVTNPOHDFFCJ-UHFFFAOYSA-N fentanyl citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 IVLVTNPOHDFFCJ-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 229960004279 formaldehyde Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- SRRRXFGBRKQYOV-UHFFFAOYSA-N methyl 3-methoxy-4-(oxiran-2-ylmethoxy)benzoate Chemical compound COC1=CC(C(=O)OC)=CC=C1OCC1OC1 SRRRXFGBRKQYOV-UHFFFAOYSA-N 0.000 description 1
- HSVFHVJMOZOSRE-UHFFFAOYSA-N methyl 4-(3-amino-2-hydroxypropoxy)-3-methoxybenzoate Chemical compound COC(=O)C1=CC=C(OCC(O)CN)C(OC)=C1 HSVFHVJMOZOSRE-UHFFFAOYSA-N 0.000 description 1
- NNLMSSXJSXUUOI-UHFFFAOYSA-N methyl 4-[3-(benzhydrylamino)-2-hydroxypropoxy]-3-methoxybenzoate;hydrochloride Chemical compound Cl.COC1=CC(C(=O)OC)=CC=C1OCC(O)CNC(C=1C=CC=CC=1)C1=CC=CC=C1 NNLMSSXJSXUUOI-UHFFFAOYSA-N 0.000 description 1
- FDLVCUOMIAFXNG-UHFFFAOYSA-N methyl(propyl)azanium;chloride Chemical compound Cl.CCCNC FDLVCUOMIAFXNG-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- ZURJDMADOBDUGA-UHFFFAOYSA-N n-(oxiran-2-ylmethyl)-n-phenylaniline Chemical compound C=1C=CC=CC=1N(C=1C=CC=CC=1)CC1CO1 ZURJDMADOBDUGA-UHFFFAOYSA-N 0.000 description 1
- JAPIRGXZYOKOTL-UHFFFAOYSA-N n-benzhydryl-n-[2-hydroxy-3-(2-methoxy-4-propylphenoxy)propyl]acetamide Chemical compound COC1=CC(CCC)=CC=C1OCC(O)CN(C(C)=O)C(C=1C=CC=CC=1)C1=CC=CC=C1 JAPIRGXZYOKOTL-UHFFFAOYSA-N 0.000 description 1
- LKKPQSGYINUOOH-UHFFFAOYSA-N n-benzhydryl-n-[3-(3,4-dichlorophenoxy)-2-hydroxypropyl]acetamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)N(C(=O)C)CC(O)COC1=CC=C(Cl)C(Cl)=C1 LKKPQSGYINUOOH-UHFFFAOYSA-N 0.000 description 1
- PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- NRNCYVBFPDDJNE-UHFFFAOYSA-N pemoline Chemical compound O1C(N)=NC(=O)C1C1=CC=CC=C1 NRNCYVBFPDDJNE-UHFFFAOYSA-N 0.000 description 1
- 229960000761 pemoline Drugs 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229940031826 phenolate Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- LEVJVKGPFAQPOI-UHFFFAOYSA-N phenylmethanone Chemical compound O=[C]C1=CC=CC=C1 LEVJVKGPFAQPOI-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229960004526 piracetam Drugs 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000009090 positive inotropic effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- UMSVPCYSAUKCAZ-UHFFFAOYSA-N propane;hydrochloride Chemical compound Cl.CCC UMSVPCYSAUKCAZ-UHFFFAOYSA-N 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 201000009570 retrograde amnesia Diseases 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- AGXFSSKQUOILPQ-UHFFFAOYSA-M sodium 2-hydroxy-3-methoxy-5-prop-2-enylbenzoate Chemical compound C1(=C(O)C(=CC(CC=C)=C1)C(=O)[O-])OC.[Na+] AGXFSSKQUOILPQ-UHFFFAOYSA-M 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- HJHVQCXHVMGZNC-JCJNLNMISA-M sodium;(2z)-2-[(3r,4s,5s,8s,9s,10s,11r,13r,14s,16s)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1h-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoate Chemical compound [Na+].O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C([O-])=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C HJHVQCXHVMGZNC-JCJNLNMISA-M 0.000 description 1
- CUCUZAYQPSWFGS-UHFFFAOYSA-M sodium;2-methoxy-4-propylphenolate Chemical compound [Na+].CCCC1=CC=C([O-])C(OC)=C1 CUCUZAYQPSWFGS-UHFFFAOYSA-M 0.000 description 1
- ZLUZHXGLNFCZPR-UHFFFAOYSA-M sodium;3,4-dichlorophenolate Chemical compound [Na+].[O-]C1=CC=C(Cl)C(Cl)=C1 ZLUZHXGLNFCZPR-UHFFFAOYSA-M 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229940127230 sympathomimetic drug Drugs 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 1
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
- AGGKEGLBGGJEBZ-UHFFFAOYSA-N tetramethylenedisulfotetramine Chemical compound C1N(S2(=O)=O)CN3S(=O)(=O)N1CN2C3 AGGKEGLBGGJEBZ-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/36—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP2547524.5 | 1975-10-23 | ||
DE19752547524 DE2547524A1 (de) | 1975-10-23 | 1975-10-23 | Disubstituierte phenolaether des 3-amino-2-hydroxypropans, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1085417A true CA1085417A (en) | 1980-09-09 |
Family
ID=5959934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA263,964A Expired CA1085417A (en) | 1975-10-23 | 1976-10-22 | Disubstituted phenol ethers of 3-amino-2- hydroxypropane, processes for their preparation and their use as medicaments |
Country Status (29)
Country | Link |
---|---|
US (1) | US4110472A (en, 2012) |
JP (1) | JPS5935387B2 (en, 2012) |
AT (2) | AT344682B (en, 2012) |
AU (1) | AU502167B2 (en, 2012) |
BE (1) | BE847541A (en, 2012) |
BG (2) | BG27732A3 (en, 2012) |
CA (1) | CA1085417A (en, 2012) |
CH (2) | CH623562A5 (en, 2012) |
CS (2) | CS191322B2 (en, 2012) |
DD (1) | DD128555A5 (en, 2012) |
DE (1) | DE2547524A1 (en, 2012) |
DK (1) | DK480376A (en, 2012) |
ES (1) | ES452616A1 (en, 2012) |
FI (1) | FI67075C (en, 2012) |
FR (1) | FR2328458A1 (en, 2012) |
GB (1) | GB1497500A (en, 2012) |
GR (1) | GR61598B (en, 2012) |
HU (1) | HU174097B (en, 2012) |
IE (1) | IE43745B1 (en, 2012) |
IL (1) | IL50732A (en, 2012) |
LU (1) | LU76057A1 (en, 2012) |
NL (1) | NL7611683A (en, 2012) |
NO (1) | NO143844C (en, 2012) |
PL (2) | PL110002B1 (en, 2012) |
PT (1) | PT65737B (en, 2012) |
RO (1) | RO76883A (en, 2012) |
SE (1) | SE432926B (en, 2012) |
SU (2) | SU639443A3 (en, 2012) |
ZA (1) | ZA766303B (en, 2012) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1223395B (it) * | 1987-12-01 | 1990-09-19 | Simes | Composti ad attivita' cardiovascolare |
US5541204A (en) * | 1994-12-02 | 1996-07-30 | Bristol-Myers Squibb Company | Aryloxypropanolamine β 3 adrenergic agonists |
MX2009011360A (es) | 2007-04-20 | 2010-02-12 | Acucela Inc | Compuestos derivados de estirenilo para tratar enfermedades y trastornos oftalmicos. |
FR3030514A1 (fr) * | 2014-12-18 | 2016-06-24 | Centre De Coop Int En Rech Agronomique Pour Le Dev (Cirad) | Dimeres polyaromatiques |
EP3144289A1 (en) * | 2015-09-16 | 2017-03-22 | Evonik Technochemie GmbH | [(2-ethoxy-5-trans-1-propen-1-yl)-phenoxyl]-terminated compounds |
RU2766146C2 (ru) * | 2016-10-05 | 2022-02-08 | Юниверсити Оф Питтсбург - Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн | Низкомолекулярные активаторы амфк |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3758583A (en) * | 1971-01-21 | 1973-09-11 | Syntex Corp | 2-(2-hydroxy-3-aminopropyl-1-yloxy)-1,6-dilfuoro-and-1,6-methano-{8 10{9 annulenes and the salts thereof |
-
1975
- 1975-10-23 DE DE19752547524 patent/DE2547524A1/de not_active Withdrawn
-
1976
- 1976-10-08 NO NO763442A patent/NO143844C/no unknown
- 1976-10-13 US US05/732,118 patent/US4110472A/en not_active Expired - Lifetime
- 1976-10-18 SU SU762413401A patent/SU639443A3/ru active
- 1976-10-18 CH CH1318976A patent/CH623562A5/de not_active IP Right Cessation
- 1976-10-19 AU AU18797/76A patent/AU502167B2/en not_active Expired
- 1976-10-19 BG BG034473A patent/BG27732A3/xx unknown
- 1976-10-19 BG BG035324A patent/BG31796A3/xx unknown
- 1976-10-20 PT PT65737A patent/PT65737B/pt unknown
- 1976-10-20 IL IL50732A patent/IL50732A/xx unknown
- 1976-10-21 FI FI763010A patent/FI67075C/fi not_active IP Right Cessation
- 1976-10-21 HU HU76BA3468A patent/HU174097B/hu unknown
- 1976-10-21 SE SE7611686A patent/SE432926B/xx unknown
- 1976-10-21 AT AT784476A patent/AT344682B/de not_active IP Right Cessation
- 1976-10-21 JP JP51125582A patent/JPS5935387B2/ja not_active Expired
- 1976-10-21 GB GB43725/76A patent/GB1497500A/en not_active Expired
- 1976-10-21 DD DD7600195393A patent/DD128555A5/xx unknown
- 1976-10-21 NL NL7611683A patent/NL7611683A/xx not_active Application Discontinuation
- 1976-10-21 AT AT606377A patent/AT345792B/de not_active IP Right Cessation
- 1976-10-22 IE IE2332/76A patent/IE43745B1/en unknown
- 1976-10-22 PL PL1976213281A patent/PL110002B1/pl unknown
- 1976-10-22 GR GR51997A patent/GR61598B/el unknown
- 1976-10-22 RO RO7696832A patent/RO76883A/ro unknown
- 1976-10-22 LU LU76057A patent/LU76057A1/xx unknown
- 1976-10-22 FR FR7631948A patent/FR2328458A1/fr active Granted
- 1976-10-22 DK DK480376A patent/DK480376A/da not_active Application Discontinuation
- 1976-10-22 CA CA263,964A patent/CA1085417A/en not_active Expired
- 1976-10-22 CS CS766837A patent/CS191322B2/cs unknown
- 1976-10-22 CS CS777809A patent/CS191344B2/cs unknown
- 1976-10-22 BE BE171708A patent/BE847541A/xx not_active IP Right Cessation
- 1976-10-22 ZA ZA766303A patent/ZA766303B/xx unknown
- 1976-10-22 ES ES452616A patent/ES452616A1/es not_active Expired
- 1976-10-22 PL PL1976193206A patent/PL110007B1/pl unknown
-
1977
- 1977-07-15 SU SU772502200A patent/SU664559A3/ru active
-
1980
- 1980-09-08 CH CH672680A patent/CH630058A5/de not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0210849B1 (en) | 2-hydroxy-3-phenoxypropyl amines | |
US4234595A (en) | 3-Indolyl-tertiary butylaminopropanols | |
NO151411B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater | |
PL90695B1 (en, 2012) | ||
DK152288B (da) | Analogifremgangsmaade til fremstilling af 3-(1,4-benzodioxan-2-yl-methoxy)-2-propanolaminer eller syreadditionssalte deraf | |
CA1085417A (en) | Disubstituted phenol ethers of 3-amino-2- hydroxypropane, processes for their preparation and their use as medicaments | |
NL8800683A (nl) | Farmacologisch actieve gesubstitueerde benzamiden. | |
US4460605A (en) | 2-[2'-Hydroxy-3'-(1,1-dimethylpropylamino)-propoxy]-β-phenylpropiophenone, its physiologically acceptable acid addition salts, and pharmaceutical compositions | |
EP0467325A2 (en) | Carbostyril derivatives | |
US4363808A (en) | N-(3-Phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines | |
US4608391A (en) | Catecholamine derivatives, a process for their preparation and pharmaceutical compositions thereof | |
US4181738A (en) | Catecholamine derivatives, a process for their preparation and pharmaceutical compositions thereof | |
JPH072812A (ja) | チアジアジノン | |
EP0007710A1 (en) | Bicyclo(3.1.0)hexyl-substituted carbonylaminophenoxy compounds, their preparation, and compositions containing them for use in treating mammals | |
AU653444B2 (en) | Thiadiazinone | |
US4526893A (en) | Isocarbostyril derivatives | |
HU198052B (en) | Process for producing purine derivatives substituted by side chain containing piperazinyl ring and pharmaceutical compositions comprising such compounds | |
CA1236116A (en) | Process for the production of s(-)-3-/3-acetyl-4- (3-tert.butylamino-2-hydroxy-propoxy)-phenyl/-1,1- diethylurea and its salts | |
IE47604B1 (en) | Subsituted pyrrolidines, process for their preparation,their use and medicaments containing them | |
US4340595A (en) | Aminopropanol derivatives of 6-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one and pharmaceutical formulations containing the said compounds | |
NZ202817A (en) | Morpholine carboximide or urea derivatives and pharmaceutical compositions | |
RU2075477C1 (ru) | 1-//2-(динизший алкиламино)алкил/амино/-4-замещенные тиоксантен-9-оны и фармацевтическая композиция, обладающая противоопухолевой активностью | |
CA1126296A (en) | R-n-(2-phenyl-2-hydroxyethyl)-3-phenylpropyl amines, formulations and method of treatment | |
US4252824A (en) | Amino-ethanol derivatives | |
JPH02258749A (ja) | ポリヒドロキシベンジルオキシプロパノールアミン |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |